Search

Your search keyword '"S. Supiot"' showing total 307 results

Search Constraints

Start Over You searched for: Author "S. Supiot" Remove constraint Author: "S. Supiot"
307 results on '"S. Supiot"'

Search Results

1. Stereotactic body radiation therapy for spine and non-spine bone metastases. GETUG (french society of urological radiation oncologists) recommendations using a national two-round modified Delphi survey

2. Late toxicity and quality of life from GETUG-AFU 22 study: A randomized phase II trial comparing 6 months of degarelix in combination with radiotherapy to radiotherapy alone for patients with detectable PSA after radical prostatectomy

3. A new tissue segmentation method to calculate 3D dose in small animal radiation therapy

7. DNA repair inhibitors and radiotherapy

9. External radiotherapy for prostatic cancers

10. Guide for paediatric radiotherapy procedures

11. Radiotherapy of bone metastases

15. Recommendations for stereotactic body radiation therapy for spine and non-spine bone metastases. A GETUG (French society of urological radiation oncolgists) consensus using a national two-round modified Delphi survey

16. [Clinical research in radiation oncology: how to move from the laboratory to the patient?]

17. Salvage Radiotherapy Guided by Functional Imaging for Macroscopic Local Recurrence Following Radical Prostatectomy: A Multicentric Retrospective Study

20. Specificities of clinical research in radiotherapy

21. FLASH Mechanisms Track (Oral Presentations) UHDR PROTON BEAM VS. CONVENTIONAL: HYDROGEN PEROXIDE AS FLASH EFFECT SENSOR

22. GETUG-AFU 22 Phase II Randomized Trial Evaluating Outcomes of Post-Operative Immediate Salvage Radiation Therapy with or without ADT for Patients with Persistently Elevated PSA Level

29. [Endocrine side effects of radiation therapy: Diagnosis, prevention, and treatment]

30. [Postoperative radiotherapy for prostate cancer: when to propose it? What is the place for androgen deprivation?]

31. [Combination radiotherapy-immunotherapy in genitourinary cancer]

32. [Intermediate-risk prostate cancer treated with exclusive external irradiation: Focus on anatomical sites of recurrence in two French trials]

33. [Do dose constraints to organs at risk need to be adapted when irradiation is combined with drug therapy?]

34. [Treatment of radiation-induced late effects: What's new?]

37. [Moderate or extreme hypofractionation and localized prostate cancer: The times are changing]

38. [Stereotactic ablative body radiotherapy: Which machine for which therapeutic indication? A focus on prostate cancer]

39. [Indications and outlooks of radiohormonal therapy of high-risk prostate cancers]

40. [Reference bases of radiotherapy under stereotaxic conditions for bronchopulmonary, hepatic, prostatic, upper aero-digestive, cerebral and bone tumors or metastases]

41. [Hypofractionnated radiotherapy for elderly patients with prostate cancer]

42. [Image guided radiation therapy for prostate cancer; how, when and why?]

43. [Radiotherapy of oligometastatic pelvic node relapses in patients with prostate cancer]

44. Niveaux de preuve des nouvelles techniques de radiothérapie du cancer de la prostate

46. [Spinal stereotactic body radiotherapy: French assessment in 2016]

47. [Radiotherapy for paediatric cancers]

48. [Role of radiotherapy in the management of node-positive prostate cancer]

49. [French organization of paediatric radiation treatment: Results of a survey conducted by the radiotherapy Committee of the French Society of Paediatric Cancers (SFCE)]

50. Radiothérapie en conditions stéréotaxiques en pédiatrie

Catalog

Books, media, physical & digital resources